GMMA Technology for the Development of Safe Vaccines: Meta-Analysis of Individual Patient Data to Assess the Safety Profile of Shigella sonnei 1790GAHB Vaccine in Healthy Adults, with Special Focus on Neutropenia

INTRODUCTION: Shigellosis is a major health concern among children < 5 years of age from developing countries, and there are no widely available vaccines to prevent it. The GMMA-based 1790GAHB investigational vaccine against Shigella sonnei was well tolerated and immunogenic in phase 1 and 2 stud...

Descripción completa

Detalles Bibliográficos
Autores principales: De Ryck, Iris, Sarakinou, Eleanna, Nakakana, Usman, Cilio, Giulia Luna, Ndiaye, Augustin, Vella, Venanzio, Auerbach, Joachim, Granada, Juan-Paolo, Conti, Valentino, Podda, Audino
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8960504/
https://www.ncbi.nlm.nih.gov/pubmed/35118580
http://dx.doi.org/10.1007/s40121-022-00596-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8960504/
https://www.ncbi.nlm.nih.gov/pubmed/35118580
http://dx.doi.org/10.1007/s40121-022-00596-x

Ejemplares similares